Golden Eye v Telefonica: Media CAT revisited

No items found.
21 November 2012
Tags
Litigation

The Journal of Intellectual Property Law and Practice has published an article by partner Gary Moss about Arnold J’s decision in Golden Eye v Telefonica.

Media CAT v Adams, decided in the PCC, raised the lid on how the Norwich Pharmacal jurisdiction might be open to abuse in the context of alleged infringement of copyright works by persons who might not be familiar with how the law operated and where those against whom disclosure was sought would probably find it easier to provide that disclosure rather than contest the claimants' actions.

Those issues have now been the subject of further consideration by the High Court, albeit with the advantage that the issues were being considered before the Norwich Pharmacal order had been granted rather than after the event as in Media CAT.

This article examines this latest decision and looks at what it might mean for the Norwich Pharmacal jurisdiction in the future.

To read the JIPLP article in full, click here.

Related articles

EIP recognised across the board in IAM Patent 1000, 2026
29 May 2026
We're pleased to be featured again in the IAM Patent 1000, 2026. The guide is one of the most trusted independent rankings of patent professionals worldwide, built on months of research and direct feedback from clients and peers.
Five EIP leaders recognised in WIPR 2026
11 May 2026
We are delighted to announce that five members of our team have been named in WIPR Leaders 2026: Jerome Spaargaren, Heather McCann, Gary Moss, Andrew Sharples, and Sebastian Fuchs.
EIP recognsied for strategic leadership in patent law at the Professional Services Management Excellence Awards
26 March 2026
EIP has been recognised with two Professional Services Management Excellence Awards 2026, including Excellence in Strategic Leadership and Best in Theme: Leadership. The awards reflect the firm’s commitment to aligning patent expertise with commercial insight, strengthening leadership across the firm and delivering patent strategy that supports investment, growth and high‑value business decisions.